Gossamer Bio (GOSS) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$180.2 million.
- Gossamer Bio's Enterprise Value rose 4489.14% to -$180.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.2 million, marking a year-over-year increase of 4489.14%. This contributed to the annual value of -$294.5 million for FY2024, which is 64.33% up from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Enterprise Value is -$180.2 million, which was up 4489.14% from -$212.9 million recorded in Q2 2025.
- Gossamer Bio's 5-year Enterprise Value high stood at -$162.1 million for Q2 2023, and its period low was -$354.5 million during Q2 2024.
- For the 4-year period, Gossamer Bio's Enterprise Value averaged around -$261.0 million, with its median value being -$257.9 million (2025).
- Per our database at Business Quant, Gossamer Bio's Enterprise Value crashed by 11864.97% in 2024 and then soared by 4489.14% in 2025.
- Over the past 4 years, Gossamer Bio's Enterprise Value (Quarter) stood at -$255.7 million in 2022, then decreased by 15.94% to -$296.4 million in 2023, then increased by 0.64% to -$294.5 million in 2024, then surged by 38.81% to -$180.2 million in 2025.
- Its last three reported values are -$180.2 million in Q3 2025, -$212.9 million for Q2 2025, and -$257.9 million during Q1 2025.